Skip to main content
Linda Duska, MD, Obstetrics & Gynecology, Charlottesville, VA

Linda R Duska MD

Gynecologic Oncology, Hospice & Palliative Medicine


Professor of Obstetrics & Gynecology, University VA School of Medicine

Join to View Full Profile
  • 1240 Lee StCharlottesville, VA 22908

  • Phone+1 434-924-9333

  • Fax+1 434-244-7526

Dr. Duska is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Gynecologic Oncology, 1995 - 1998
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1991 - 1995
  • New York University School of Medicine
    New York University School of MedicineClass of 1991

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2008 - 2026
  • FL State Medical License
    FL State Medical License 2019 - 2021
  • MA State Medical License
    MA State Medical License 1995 - 2012
  • Hospice and Palliative Medicine
    American Board of Internal Medicine Hospice and Palliative Medicine
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • Gynecologic Oncology
    American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2012-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Surgery Is Critical to a Multidisciplinary Approach to Ovarian Cancer 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

  • Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
    Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian CancerMay 13th, 2025
  • Bevacizumab Ovarian Cancer Trial: Real-World Impact?
    Bevacizumab Ovarian Cancer Trial: Real-World Impact?May 13th, 2025
  • Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
    Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian CancerMay 13th, 2025
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: